Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - EU Market Recap: FTSE 100 (0.68%) to 7628.75, DAX (0.65%) to 16921.96, CAC40 (0.36%) to 7611.26, STOXX 600 (0.23%) to 485.63

Feb 07 ,2024

  • Synopsis:

    • European equity markets closed mostly lower with the exception of Denmark +1.0%. Telecom, Personal Care and Oil/Gas were the worst performers, while Technology, Auto/Parts and Construction/Materials outperformed.

    • Rate stabilization supportive for equity markets after recent bout of Fed pivot repricing amid US data strength. Market expectations wound back to 4-5 Fed rate cuts in 2024 vs the 7 being priced last month. Comes amid debate over path of disinflation in light of resilient macro data and policymaker wariness about easing too soon. ECB officials edging towards a rate cut but warn against easing too soon. Schnabel says incoming data and recent events in Red Sea cautions against adjusting policy stance.

    • In macro-data, German December industrial production worse than forecast (1.6%) m/m vs consensus (0.4%) and down from prior month revised (0.2%) from (0.7%) whilst UK Halifax house price data show fourth consecutive increase and reinforce expectations that housing market has stabilized +1.3% m/m vs consensus +0.8%, equating to +2.5% y/y vs consensus +1.9% and prior revised +1.8% from +1.7% and prior +1.1%. France Dec. trade balance deficit widens to (€6.83B) vs consensus (€6.0B) and prior revised to (€5.94B) from (€5.94B) while Italy retail sales miss (0.1%) m/m vs consensus +0.2% and prior revised +0.3% from +0.4%. Elsewhere, Spain industrial production contracting in line with consensus (0.2%) y/y vs consensus (0.2%) and prior revised +0.9% from +0.8%.

    • On a busy earnings calendar, DACHs region companies releasing their results included Siemens Energy (ENR.GR) confirming prelim. Q1 results and reporting Q1 EPS €1.79 vs FactSet €1.25, METRO (B4B.GR) Q1 EPS €0.36 vs consensus €0.27, TeamViewer (TMV.GR) reporting Q4 adjusted EBITDA €62.4M vs FactSet €69.3M, CTS Eventim (EVD.GR) preliminary FY adjusted EBITDA €501.4M vs prior guidance well above €400M, FactSet €447.6M, Voestalpine (VOE.AV) Q3 EPS €0.45 vs FactSet €0.46 and Hannover Re (HNR1.GR) announcing prelim FY23 EBIT €1.97B; likely not comparable to FactSet €2.40B. In France, TotalEnergies (TTE.FP) reports Q4 adj net income $5.23B vs consensus $5.30B, hikes divi by ~7% and announces $2B of buybacks in Q1 while Amundi (AMUN.FP) reports Q4 adj net income €313M vs consensus €314M. In Italy, Banca Monte dei Paschi di Siena (BMPS.IM) reports Q4 net income €1.12B and unclear if comparable to FactSet €316.8M.

    • In the Nordics, Equinor (EQNR.NO) reports Q4 adjusted net income $1.88B vs consensus $2.33B, Pandora (PNDORA.DC) final Q4 EPS DKK29.40 vs FactSet DKK31.13, hikes divi by 12.5% and announces DKK4.0B buyback whilst Telenor (TEL.NO) reports Q4 EBITDA before items NOK8.47B vs consensus NOK8.57B, H. Lundbeck (HLUN.B.DC) reports Q4 Adj. EPS DKK0.58 vs FactSet DKK0.65, Vestas Wind Systems (VWS.DC) reports FY net income €78M vs FactSet €72.3M, Ørsted (ORSTED.DC) reports Q4 EBITDA excl. new partnerships DKK8.62B vs FactSet DKK6.29B, pauses dividends for financial years 2023-2025 and presents updated business plan following comprehensive portfolio review, Svenska Handelsbanken (SHB.A.SS) reports Q4 EPS SEK3.66 vs FactSet SEK3.45 and Schibsted (SCHA.NO) reports Q4 Adj. EPS NOK0.47 vs consensus NOK1.02; updates medium-term targets for jobs.

    • Elsewhere, Akzo Nobel (AKZA.NA) reports Q4 EPS €0.24 vs consensus €0.69 while Smurfit Kappa Group (SKG.LN) reports FY EPS €3.49 ex-items vs FactSet €3.45, hikes divi by 10% to 118.4c per share. In notable UK M&A news, Barratt Developments PLC (BDEV.LN) announced a recommended offer for Redrow plc (RDW.LN), offerings for each Redrow Share 1.44 new Barratt shares (RDW.LN) in deal worth ~£2.5B.

  • Digest:

    • Sectors - STOXX Europe 600:

      • Outperformers:

        • Technology +0.75%, Autos & Parts +0.51%, Construct & Mtls +0.36%, Consumer Products and Services +0.18%, Health Care +0.14%, Media +0.13%, Ind Goods & Svcs (0.08%), Food, Beverage and Tobacco (0.17%)

      • Underperformers:

        • Telecom (1.19%), Personal Care Drug and Grocery Stores (1.13%), Energy(1.06%), Basic Resources (1.05%), Banks (0.87%), Retail (0.73%), Utilities (0.71%), Chemicals (0.55%), Insurance (0.54%), Real Estate (0.48%), Financial Svcs (0.42%)

    • Macro:

      • Central banks:

        • ECB's Schnabel says incoming data and Red Sea tensions cautions against adjusting policy -link

        • Dhingra urges BoE not to take a risk with the economy - FT

        • UK lawmakers criticize BoE's QT framework - London Times

      • Netherlands:

        • Talks between Wilder's PVV and three other parties fail again - NLTimes

      • Germany

        • German industrial production weaker than forecast - Destasis

      • UK:

        • Halifax house price data sees larger than expected increase - Halifax

        • NIESR says UK living standards to turn corner slowly - Reuters

        • Improving UK economy no election game-changer for Sunak - Reuters

        • Better times coming for UK mortgage holders - FT

        • New CBI president says it is pushing for Labour to soften workers' right pledges - FT

        • Brussels weakens plans to shift derivatives clearing from London - FT

    • Company news:

      • Notable Gainers

        • +18.6% CEVI.SS (CellaVision SEK261.00, +41.00) -- Q4 earnings

        • +17.5% REDX.LN (Redx Pharma £0.24, +0.04) -- to sell KRAS inhibitor program to Jazz Pharmaceuticals (JAZZ) for $10M (£7.9M) up front

        • +14.9% HOFI.SS (Hoist Finance SEK40.95, +5.30) -- reports Q4 EPS SEK1.82 vs year-ago SEK0.19; Confirms SEK100M share buyback

        • +14.8% RDW.LN (Redrow £6.89, +0.89) --

          • reports H1 EPS 18.7p vs year-ago 45.4p; guides FY24

          • Barratt Developments announces recommended offer for Redrow; offers for each Redrow Share 1.44 new Barratt shares

            • -5.5% BDEV.LN (Barratt Developments £5.01, -0.29) -- H1 earnings

        • +8.2% ADDT.B.SS (Addtech SEK244.20, +18.60) -- Q3 earnings

        • +8.1% BIOG.B.SS (BioGaia SEK122.10, +9.10) -- Q4 earnings

        • +6.4% VWS.DC (Vestas Wind Systems DKK200.20, +11.98) -- FY earnings

        • +6.3% ZIN.LN (Zinc Media Group £0.85, +0.05) -- FY trading update

        • +6.2% LAGR.B.SS (Lagercrantz Group SEK143.20, +8.40) -- rebound; Redeye says "company will continue to deliver strong growth from acquisitions in the coming quarters while organic growth will likely be soft."

        • +5.8% LNA.FP (LNA Santé €20.85, +1.15) -- reports preliminary FY revenue €720M vs FactSet €749.8M [3 est, €742.4-754.7M]

        • +5.5% BMPS.IM (Banca Monte dei Paschi di Siena €3.56, +0.19) -- Q4 earnings

        • +5.5% EVD.GR (CTS Eventim €66.75, +3.45) -- reports preliminary FY adjusted EBITDA €501.4M vs prior guidance well above €400M, FactSet €447.6M [10 est, €411.1-476M]

        • +5.4% TMV.GR (TeamViewer €14.39, +0.74) -- Q4 earnings

        • +5.2% ITAB.SS (ITAB Shop Concept SEK14.20, +0.70) -- Q4 earnings

        • +5.1% SHB.A.SS (Svenska Handelsbanken SEK119.10, +5.75) -- reports Q4 EPS SEK3.66 vs FactSet SEK3.45 [13 est, SEK3.13-3.92]

        • +5.0% CLAS.B.SS (Clas Ohlson SEK154.20, +7.30) -- Jan sales

        • +4.5% SCHA.NO (Schibsted NOK322.20, +14.00) -- reports Q4 Adj. EPS NOK0.47 vs consensus NOK1.02; updates medium-term targets for Jobs

        • +4.0% CARL.B.DC (Carlsberg DKK941.40, +36.40) -- reports FY Adj. EPS continuing ops DKK54.6 vs consensus DKK52.3; announces new DKK 1.0B share buyback program

        • +3.5% AAK.SS (AarhusKarlshamn SEK243.00, +8.20) -- Q4 earnings

        • +3.4% SK3.ID (Smurfit Kappa Group €34.80, +1.13) -- FY earnings

        • +2.7% EVT.GR (Evotec €14.52, +0.39) -- Evotec Biologics expands development and manufacturing agreement with ABL for broadly neutralising antibodies against HIV

        • +2.6% SECU.B.SS (Securitas SEK102.40, +2.60) -- Q4 earnings

        • +2.5% LIAB.SS (Lindab International SEK203.40, +4.90) -- Q4 earnings

        • +2.3% BPSO.IM (Banca Popolare di Sondrio €6.71, +0.15) -- reports FY net income attributable €461.2M vs FactSet €453.0M [5 est, €428-471.4M]

        • +1.9% GRI.LN (Grainger £2.66, +0.05) -- Trading Update: YTD Like-for-like rental growth +8.4%

      • Notable Decliners

        • -19.4% ALCJ.FP (Crossject €4.07, -0.98) -- strategic update

        • -18.1% A28890.GR (CompuGroup Medical €32.78, -7.22) -- FY earnings

        • -16.4% PZC.LN (PZ Cussons £1.07, -0.21) -- H1 earnings

        • -15.9% IRLAB.A.SS (IRLAB Therapeutics SEK12.15, -2.30) -- reports Q4 EPS (SEK0.67) vs year-ago (SEK0.64)

        • -13.0% HDD.GR (Heidelberger Druckmaschinen €0.93, -0.14) -- reports Q3 EPS €0.00 vs year-ago €0.04

        • -9.7% CREO.LN (Creo Medical Group £0.37, -0.04) -- FY trading update

        • -9.4% EQS.FP (Equasens Group €48.30, -5.00) -- prelim FY sales

        • -8.9% BAB.LN (Babcock International Group £4.24, -0.42) -- announces no new information on trading will be shared at today's CMD

        • -7.8% EQNR.NO (Equinor NOK284.60, -23.95) -- Q4 earnings

        • -7.8% AFM.LN (Alpha Financial Markets Consulting £3.42, -0.29) -- FY trading update

        • -7.6% VRS.LN (Versarien £0.00, -0.00) -- legal claims

        • -7.4% FUTR.LN (Future Plc £6.65, -0.53) -- issues AGM trading update; 4M overall performance broadly in-line with expectations

        • -6.3% ATO.FP (ATOS SE €2.64, -0.18) -- ATOS SE and Kretinsky talks over sale of legacy IT business have reportedly stalled - Bloomberg

        • -6.1% SBRY.LN (J Sainsbury £2.59, -0.17) -- strategy update

        • -6.1% BILI.A.SS (Bilia SEK114.60, -7.50) -- Q4 earnings

        • -5.6% FLNG.NO (Flex LNG NOK286.00, -17.00) -- Q4 earnings

        • -5.6% SANOMA.FH (Sanoma €6.35, -0.38) -- reports Q4 operational EPS (€0.22) vs year-ago (€0.07)

        • -5.3% VOE.AV (Voestalpine €25.90, -1.46) -- Q3 earnings

        • -5.2% DHL.GR (DHL Group €42.09, -2.32) -- KfW starts selling 50M shares in Deutsche Post AG

        • -5.0% FORTUM.FH (Fortum €11.78, -0.63) -- Q4 earnings; strategic focus and targets update

        • -4.6% COIC.SS (Concentric SEK160.00, -7.80) -- Q4 earnings

        • -3.7% B4B.GR (METRO €6.11, -0.23) -- reports Q1 EPS €0.36 vs consensus €0.27

        • -3.7% STB.NO (Storebrand NOK92.08, -3.58) -- Q4 earnings

        • -3.2% TTE.FP (TotalEnergies €58.39, -1.91) -- reports Q4 adj net income $5.23B vs consensus $5.30B; hikes divi by ~7% and announces $2B of buybacks in Q1

        • -3.2% SF.SS (Stillfront Group SEK10.00, -0.34) -- reports Q4 EPS SEK0.02 vs year-ago SEK0.42

        • -2.6% FIA1S.FH (Finnair €0.03, -0.00) -- reports January traffic +1.3% y/y

        • -2.6% DNO.NO (DNO ASA NOK8.80, -0.23) -- DNO acquires 25% interest in the Arran field on the UK Continental Shelf from ONE-Dyas E&P Limited for $70M plus contingent amount up to $5M

        • -2.3% AMUN.FP (Amundi €60.70, -1.40) -- Q4 earnings; acquisition

        • -2.3% AKZA.NA (Akzo Nobel €69.60, -1.64) -- reports Q4 EPS €0.24 vs consensus €0.69

        • -2.1% JEN.GR (Jenoptik €28.90, -0.62) -- prelim FY earnings

        • -2.0% SPNO.DC (Spar Nord Bank DKK115.60, -2.30) -- reports FY EPS DKK19.90 vs year-ago DKK11.2

        • -1.8% ORSTED.DC (Ørsted DKK378.60, -6.90) --

          • reports Q4 EBITDA excl. new partnerships DKK8.62B vs FactSet DKK6.29B [5 est, DKK5.87-7.12B]

          • pauses dividends for financial years 2023-2025; presents updated business plan following comprehensive portfolio review

    • EU companies reporting tomorrow:

      • Earnings:

        • Benelux: Unibail-Rodamco-Westfield (URW.NA), Adyen (ADYEN.NA), ArcelorMittal (MT.NA), Flow Traders (FLOW.NA), Sligro Food (SLIGR.NA), KBC Group (KBC.BB), Barco (BAR.BB), Ontex (ONTEX.BB)

        • Denmark: A.P. Moller-Maersk (MAERSK.B.DC), ALK-Abello (ALK.B.DC), GN Store Nord (GN.DC), Alm. Brand (ALMB.DC), Solar (SOLAR.B.DC), Gyldendal (GYLD.A.DC),

        • DACHs: Siemens (SIE.GR), Nemetschek (NEM.GR), KWS SAAT & Co. (KWS.GR), Verbio (VBK.GR), Hamborner REIT (HABA.GR), Deutsche Beteiligungs (DBAN.GR), Swisscom (SCMN.SW), Banque Cantonale Vaudoise (BCVN.SW), Swiss Prime Site (SPSN.SW), Leonteq (LEON.SW)

        • Finland: Neste Corp. (NESTE.FH), Sampo (SAMPO.FH), Huhtamaki (HUH1V.FH), Metsa Board (METSB.FH), Outokumpu (OUT1V.FH), Fiskars (FSKRS.FH), Caverion (CAV1V.FH), Aktia Bank (AKTIA.FH), Harvia (HARVIA.FH), Etteplan (ETTE.FH), Verkkokauppa.com (VERK.FH)

        • France: L'Oreal (OR.FP), Kering (KER.FP), Credit Agricole (ACA.FP), Publicis Groupe (PUB.FP), Societe Generale (GLE.FP), Ipsen (IPN.FP), ALD (ALD.FP), X-FAB Silicon Foundries (XFAB.FP)

        • Norway: Aker BP (AKRBP.NO), Orkla (ORK.NO), SpareBank 1 SR-Bank (SRBNK.NO), SpareBank 1 SMN (MING.NO), Aker Solutions (AKSO.NO), Atea (ATEA.NO), Elkem (ELK.NO), Veidekke (VEI.NO), Odfjell (ODF.NO), SpareBank 1 Nord-Norge (NONG.NO), DNO (DNO.NO), Gram Car Carriers (GCC.NO), REC Silicon (RECSI.NO), Norske Skog (NSKOG.NO), OKEA (OKEA.NO), XXL (XXL.NO)

        • Sweden: Swedish Orphan Biovitrum (SOBI.SS), Wallenstam (WALL.B.SS), Mycronic (MYCR.SS), Pandox (PNDX.B.SS), FastPartner (FPAR.A.SS), Bufab (BUFAB.SS), New Wave (NEWA.B.SS), Modern Times Group MTG (MTG.B.SS), Mips (MIPS.SS), Boozt (BOOZT.SS), Inwido (INWI.SS), Attendo (ATT.SS), XANO Industri (XANO.B.SS), Ambea (AMBEA.SS), BICO Group (BICO.SS), Coor Service Management (COOR.SS), Green Landscaping (GREEN.SS), Knowit (KNOW.SS), MilDef Group (MILDEF.SS), Proact IT Group (PACT.SS), Bactiguard (BACTI.B.SS), Ework (EWRK.SS), PowerCell Sweden (PCELL.SS), I.A.R. Systems (IAR.B.SS), Bulten (BULTEN.SS), RugVista (RUG.SS), Infant Bacterial Therapeutics (IBT.B.SS), Humana (HUM.SS), G5 Entertainment (G5EN.SS), Sivers Semiconductors (SIVE.SS), Pricer (PRIC.B.SS), Studsvik (SVIK.SS)

        • Southern Europe: Banco BPM (BAMI.IM), Banca Mediolanum (BMED.IM), Banca Generali (BGN.IM), Credito Emiliano (CE.IM), BFF Bank (BFF.IM), Cementir (CEM.IM), Sanlorenzo (SL.IM), Banca IFIS (IF.IM), Banco di Desio e della Brianza (BDB.IM), NH Hotel (NHH.SM)

        • UK: AstraZeneca (AZN.LN), Unilever (ULVR.LN), British American Tobacco (BATS.LN), Redrow (RDW.LN)

      • Trading Update: Compass Group (CPG.LN), Anglo American (AAL.LN), Watches of Switzerland (WOSG.LN), Assystem (ASY.FP), Ubisoft Entertainment (UBI.FP), Delta Plus (ALDLT.FP), Waga Energy (WAGA.FP) AKWEL (AKW.FP), Guerbet (GBT.FP), Vente-Unique.com (ALVU.FP), Claranova (CLA.FP), ICAPE (ALICA.FP), Wallix Group (ALLIX.FP)

      • CMD/events: Revolution Beauty Group (REVB.LN), Waga Energy (WAGA.FP)

  • Data:

    • Economics:

      • UK Jan Halifax House Prices +2.5% y/y vs cons +1.9% and prior revised +1.8% from +1.7%

      • Switzerland Jan Unemployment Rate (sa) 2.2% vs cons 2.2% and prior 2.2%

      • Dec Industrial Production:

        • Germany (1.6%) m/m vs cons (0.4%) and prior revised (0.2%) from (0.7%)

        • Spain (0.2%) y/y vs cons (0.2%) and prior revised +0.9% from +0.8%

      • France Dec Trade Balance (€6.83B) vs cons (€6.0B) and prior (€5.94B)

      • Italy Dec Retail Sales +0.3% y/y vs cons +1.0% and prior revised +1.4% from +1.5%; (0.1%) m/m vs cons +0.2% and prior revised +0.3% from +0.4%

      • Dec Manufacturing Production

        • Denmark +5.7% m/m vs cons (6.7%) and prior revised +8.1% from +9.9%

        • Norway +0.3% m/m vs cons +0.5% and prior (0.3%)

    • Markets:

      • WTI Crude (Mar 24): +$0.42 or +0.57% to $73.73

      • €-$ +0.0012 or +0.11% to 1.0768

      • £-$ +0.0027 or +0.21% to 1.2626

      • €-£ (0.0007) to 0.8529

      • S&P 500 +0.68%

      • Performance year-to-date

        • FTSE 100: (1.35%)

        • DAX: +1.02%

        • CAC: +0.90%

        • MIB: +2.06%

        • Stoxx 600: +1.39%

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE